Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
OMRON Corporation (6645.T)
Kyoto, JP
OMRON Corporation is a global enterprise operating across diverse sectors, including industrial automation, electronic and mechanical components, social infrastructure systems, and healthcare. Its Industrial Automation division offers a comprehensive range of products such as sensors, switches, safety and control devices, relays, advanced automation platforms, motion control systems, robotics, equipment for energy efficiency and environmental management, and power supply solutions. The Electronic and Mechanical Components segment supplies essential items like relays, switches, connectors, sensors, and specialized components for entertainment devices. Through its Social Systems, Solutions and Service Business, OMRON delivers diverse terminal and system solutions, including photovoltaic inverters and battery storage units, advanced railway station equipment (such as automated ticket barriers and vending machines), traffic and road management technology, payment processing systems, and Uninterruptible Power Supply (UPS) units to safeguard against power interruptions. Furthermore, this division provides a spectrum of software development and ongoing maintenance services crucial for supporting societal infrastructure, alongside specialized transport management and infrastructure monitoring systems. Its Healthcare division manufactures a variety of medical and wellness products, including blood pressure monitors, nebulizers, electrotherapy TENS devices, digital thermometers, body composition analyzers, activity trackers, and automated external defibrillators (AEDs), among others. OMRON Corporation has also formed a strategic partnership with JMDC Inc. to collaboratively create personalized solutions aimed at preventing the worsening of conditions and providing care, which involves predicting the risk of specific patient events to support prescription medication regimens and lifestyle adjustments. Tracing its origins back to its founding in Kyoto, Japan, in 1933, the company was initially known as OMRON Tateisi Electronics Co. before officially adopting the name OMRON Corporation in January 1990.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.79% | -4.79% | +21.38% | +22.45% | +46.59% | +45.35% | +40.29% | -29.01% | -29.86% | +74.94% | +231.51% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 6 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Machinery: +7.4%-4.3% Q1'26: -31.1% (vs Q1'25)
-
EPS growth Industrial - Machinery: +15.6%+75.2% ★ Q1'26: +55.8% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Machinery: +38.2%+5.2% Q1'26: +6.5% (vs Q1'25)
-
EBIT margin Industrial - Machinery: +10.0%+7.8% Q1'26: +17.0% (vs Q1'25)
-
ROIC Industrial - Machinery: +6.8%+4.1% Q1'26: +7.8% (vs Q1'25)
-
Share dilution Industrial - Machinery: +0.0%-0.1% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Machinery: -0.65×2.57× Q1'26: 1.73× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 10 Rev. Ana. 9 EPS Ana. |
Mar 2027 7 Rev. Ana. 6 EPS Ana. |
Mar 2028 9 Rev. Ana. 9 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
847.25B
est: 848.14B (-0.1%)
|
833.60B
est: 834.53B (-0.1%)
|
794.20B
est: 785.84B (+1.1%)
|
859.98B
est: 857.12B (+0.3%)
|
732.58B
est: 854.05B (-14.2%)
|
677.98B
est: 672.78B (+0.8%)
|
655.53B
est: 643.56B (+1.9%)
|
762.93B
est: 761.27B (+0.2%)
|
876.08B
est: 863.38B (+1.5%)
|
818.76B
est: 799.12B (+2.5%)
|
801.75B
est: 803.88B (-0.3%)
|
850.11B
818.61B – 865.64B
+5.7% YoY
|
908.88B
853.77B – 953.13B
+6.9% YoY
|
951.74B
876.88B – 1.01T
+4.7% YoY
|
944.10B
942.46B – 945.74B
-0.8% YoY
|
974.20B
906.18B – 1.03T
+3.2% YoY
|
| EBITDA |
114.93B
est: 98.25B (+17.0%)
|
93.75B
est: 96.67B (-3.0%)
|
96.53B
est: 91.03B (+6.0%)
|
115.72B
est: 99.29B (+16.5%)
|
97.71B
est: 98.93B (-1.2%)
|
80.47B
est: 77.93B (+3.2%)
|
85.24B
est: 74.55B (+14.3%)
|
112.68B
est: 88.18B (+27.8%)
|
127.27B
est: 100.01B (+27.3%)
|
65.16B
est: 97.77B (-33.4%)
|
87.49B
est: 98.35B (-11.0%)
|
104.00B
100.15B – 105.90B
+5.7% YoY
|
111.19B
104.45B – 116.61B
+6.9% YoY
|
116.44B
107.28B – 123.87B
+4.7% YoY
|
115.50B
115.30B – 115.70B
-0.8% YoY
|
119.18B
110.86B – 125.91B
+3.2% YoY
|
| EBIT |
86.59B
est: 68.55B (+26.3%)
|
62.29B
est: 67.45B (-7.7%)
|
67.57B
est: 63.52B (+6.4%)
|
86.25B
est: 69.28B (+24.5%)
|
67.25B
est: 69.03B (-2.6%)
|
54.76B
est: 54.38B (+0.7%)
|
62.48B
est: 52.02B (+20.1%)
|
89.32B
est: 61.53B (+45.2%)
|
100.69B
est: 69.79B (+44.3%)
|
34.34B
est: 69.79B (-50.8%)
|
54.04B
est: 70.20B (-23.0%)
|
74.24B
71.49B – 75.60B
+5.7% YoY
|
79.37B
74.56B – 83.24B
+6.9% YoY
|
83.12B
76.58B – 88.42B
+4.7% YoY
|
82.45B
82.31B – 82.59B
-0.8% YoY
|
85.08B
79.14B – 89.88B
+3.2% YoY
|
| Net Income |
62.17B
est: 57.93B (+7.3%)
|
47.29B
est: 43.51B (+8.7%)
|
45.99B
est: 42.59B (+8.0%)
|
63.16B
est: 57.48B (+9.9%)
|
54.32B
est: 48.74B (+11.5%)
|
23.45B
est: 72.26B (-67.6%)
|
43.31B
est: 42.02B (+3.1%)
|
61.40B
est: 61.49B (-0.2%)
|
73.86B
est: 67.43B (+9.5%)
|
8.11B
est: -14.92B (+154.3%)
|
16.27B
est: 14.37B (+13.2%)
|
34.19B
29.00B – 36.28B
+137.9% YoY
|
45.15B
40.72B – 50.06B
+32.1% YoY
|
54.13B
43.78B – 63.04B
+19.9% YoY
|
54.30B
53.80B – 54.80B
+0.3% YoY
|
73.90B
67.19B – 79.31B
+36.1% YoY
|
| SGA |
198.10B
est: 253.35B (-21.8%)
|
205.74B
est: 249.28B (-17.5%)
|
193.54B
est: 234.74B (-17.6%)
|
212.48B
est: 256.03B (-17.0%)
|
208.90B
est: 255.11B (-18.1%)
|
202.95B
est: 200.96B (+1.0%)
|
192.69B
est: 192.24B (+0.2%)
|
213.23B
est: 227.40B (-6.2%)
|
243.02B
est: 257.90B (-5.8%)
|
261.98B
est: 238.70B (+9.7%)
|
258.77B
est: 240.13B (+7.8%)
|
253.93B
244.52B – 258.57B
+5.7% YoY
|
271.49B
255.03B – 284.71B
+6.9% YoY
|
284.29B
261.93B – 302.44B
+4.7% YoY
|
282.01B
281.52B – 282.50B
-0.8% YoY
|
291.00B
270.68B – 307.41B
+3.2% YoY
|
| EPS |
283.89
est: 294.19 (-3.5%)
|
218.95
est: 220.99 (-0.9%)
|
215.09
est: 216.31 (-0.6%)
|
296.85
est: 291.94 (+1.7%)
|
260.78
est: 247.54 (+5.3%)
|
114.34
est: 367.00 (-68.8%)
|
214.72
est: 213.40 (+0.6%)
|
305.65
est: 312.31 (-2.1%)
|
372.19
est: 342.44 (+8.7%)
|
41.17
est: -75.76 (+154.3%)
|
82.64
est: 73.63 (+12.2%)
|
162.18
147.27 – 184.26
+120.3% YoY
|
238.49
206.80 – 254.25
+47.0% YoY
|
277.73
222.32 – 320.17
+16.5% YoY
|
275.78
273.25 – 278.31
-0.7% YoY
|
375.30
341.23 – 402.82
+36.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | B | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 3/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Global X - Robotics & Artificial Intelligence UCITS ETF BOTZ.L | 2.36% | 3.68M | 0.50% |
| 2 | Global X - Robotics & Artificial Intelligence UCITS ETF BOTG.L | 2.36% | 599.2K | 0.50% |
| 3 | Global X - Robotics & Artificial Intelligence ETF BOTZ | 1.67% | 57.48M | 0.68% |
| 4 | VanEck Robotics ETF IBOT | 1.64% | 1.60M | 0.47% |
| 5 | Global X Robo Global Robotics and Automation ETF ROBO.AX | 1.28% | 2.75M | 0.69% |
| 6 | ROBO Global Robotics and Automation Index ETF ROBO | 1.25% | 22.90M | 0.95% |
| 7 | ALPS Disruptive Technologies ETF DTEC | 1.05% | 745.0K | 0.50% |
| 8 | iShares MSCI Japan Small-Cap ETF SCJ | 0.49% | 1.25M | 0.50% |
| 9 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.48% | 2.74M | 0.58% |
| 10 | Sparkline International Intangible Value ETF DTAN | 0.48% | 70.1K | 0.55% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Junta Tsujinaga | President, Chief Executive Officer & Representative Director | 213M | male |
| Kiichiro Miyata | EVice President, Chief Technology Officer & Representative Director | 110M | male |
| Masahiko Tomita | Senior Managing Executive Officer, CHRO & Director | 82M | male |
| Seigo Kinugawa | Managing Executive Officer and Senior GM of Global Business Process & IT Innovation HQ | — | male |
| Seiji Takeda | Sr. Managing Executive Officer, CFO & Senior GM of Global Strategy HQ | — | male |
| Shizuto Yukumoto | Managing Executive Officer & Director | — | male |
| Toyoharu Tamoi | Executive Officer, Chief of Global Finance Division & Senior GM of Accounting HQ | — | male |
| Tsutomu Igaki | Managing Executive Off, SGM of Global Corporate Comm. & Engagement HQ and Sustainability Executive | — | male |
| Yoshichika Tanabe | Executive Officer and Senior GM of Global Risk Management & Legal HQ | — | — |
| Ayumu Okada | Managing Executive Officer President & CEO of OMRON HEALTHCARE Co., Ltd. | — | — |
| Yukitaka Kamio | Executive Officer and Senior GM of Sales & Marketing Div. HQ, Device & Module Solutions Company | — | — |
| Kazuki Minami | Senior General Manager of Global Human Resources & Administration HQ | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6645.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
